These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21381983)

  • 1. In vitro cell culture models to study the corneal drug absorption.
    Reichl S; Kölln C; Hahne M; Verstraelen J
    Expert Opin Drug Metab Toxicol; 2011 May; 7(5):559-78. PubMed ID: 21381983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell culture models of the human cornea - a comparative evaluation of their usefulness to determine ocular drug absorption in-vitro.
    Reichl S
    J Pharm Pharmacol; 2008 Mar; 60(3):299-307. PubMed ID: 18284809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corneal cell culture models: a tool to study corneal drug absorption.
    Dey S
    Expert Opin Drug Metab Toxicol; 2011 May; 7(5):529-32. PubMed ID: 21500964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a serum-free human cornea construct for in vitro drug absorption studies: the influence of varying cultivation parameters on barrier characteristics.
    Hahne M; Reichl S
    Int J Pharm; 2011 Sep; 416(1):268-79. PubMed ID: 21771646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Culture model of human corneal epithelium for prediction of ocular drug absorption.
    Toropainen E; Ranta VP; Talvitie A; Suhonen P; Urtti A
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2942-8. PubMed ID: 11687540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cornea construct HCC-an alternative for in vitro permeation studies? A comparison with human donor corneas.
    Reichl S; Döhring S; Bednarz J; Müller-Goymann CC
    Eur J Pharm Biopharm; 2005 Jul; 60(2):305-8. PubMed ID: 15939241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalidation of a human cornea construct as an alternative to animal corneas for in vitro drug absorption studies.
    Hahne M; Zorn-Kruppa M; Guzman G; Brandner JM; Haltner-Ukomado E; Wätzig H; Reichl S
    J Pharm Sci; 2012 Aug; 101(8):2976-88. PubMed ID: 22581751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models.
    Juretić M; Cetina-Čižmek B; Filipović-Grčić J; Hafner A; Lovrić J; Pepić I
    Eur J Pharm Sci; 2018 Jul; 120():133-141. PubMed ID: 29702232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of cultured rabbit corneal epithelium for drug permeation studies: a comparison with excised rabbit cornea.
    Burgalassi S; Monti D; Brignoccoli A; Fabiani O; Lenzi C; Pirone A; Chetoni P
    J Ocul Pharmacol Ther; 2004 Dec; 20(6):518-32. PubMed ID: 15684811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance-associated protein (MRP1, 2, 4 and 5) expression in human corneal cell culture models and animal corneal tissue.
    Verstraelen J; Reichl S
    Mol Pharm; 2014 Jul; 11(7):2160-71. PubMed ID: 24456047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the drug transport in the anterior segment of the eye.
    Avtar R; Tandon D
    Eur J Pharm Sci; 2008 Oct; 35(3):175-82. PubMed ID: 18662774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-based in vitro models for predicting drug permeability.
    Sarmento B; Andrade F; da Silva SB; Rodrigues F; das Neves J; Ferreira D
    Expert Opin Drug Metab Toxicol; 2012 May; 8(5):607-21. PubMed ID: 22424145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human corneal epithelial cell model as a surrogate for corneal permeability assessment: metabolism and transport.
    Xiang CD; Batugo M; Gale DC; Zhang T; Ye J; Li C; Zhou S; Wu EY; Zhang EY
    Drug Metab Dispos; 2009 May; 37(5):992-8. PubMed ID: 19220984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and ex vivo corneal penetration and absorption models.
    Agarwal P; Rupenthal ID
    Drug Deliv Transl Res; 2016 Dec; 6(6):634-647. PubMed ID: 26762419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Culture of the primary corneal epithelium as a potential component of test batteries for eye irritancy testing.
    Sladowski D; Liberek I; Lipski K; Ozga T; Olkowska-Truchanowicz J; Szaflik J
    Toxicol In Vitro; 2005 Oct; 19(7):875-8. PubMed ID: 16061345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a convenient ex vivo model for the study of the transcorneal permeation of drugs: histological and permeability evaluation.
    Pescina S; Govoni P; Potenza A; Padula C; Santi P; Nicoli S
    J Pharm Sci; 2015 Jan; 104(1):63-71. PubMed ID: 25394188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Esterase activity of human organotypic cornea construct (HCC) as in vitro model for permeation studies].
    Meyer L; Bednarz J; Müller-Goymann CC; Reichl S
    Ophthalmologe; 2005 Oct; 102(10):971-80. PubMed ID: 15785910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of the Bovine Corneal Opacity and Permeability (BCOP) assay as an in vitro alternative to the Draize rabbit eye irritation test.
    Verstraelen S; Jacobs A; De Wever B; Vanparys P
    Toxicol In Vitro; 2013 Jun; 27(4):1298-311. PubMed ID: 23501624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics of topically applied fluconazole in the rabbit eye].
    Zhang J; Xie L; Chen Z; Zhang Q
    Zhonghua Yan Ke Za Zhi; 2002 Feb; 38(2):108-11. PubMed ID: 11955312
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    De Hoon I; Boukherroub R; De Smedt SC; Szunerits S; Sauvage F
    Mol Pharm; 2023 Jul; 20(7):3298-3319. PubMed ID: 37314950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.